Anbio Biotechnology cotiza a 4.41 USD y tiene una capitalización bursátil de $194M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, an…
| Métrica | NNNN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 87.2% | 57.0% | +30.2% |
| Operating Margin | 66.7% | -38.6% | +105.3% |
| Net Margin | 74.1% | -33.6% | +107.6% |
| FCF Margin | — | -13.9% | — |
| ROE | 21.2% | -40.4% | +61.6% |
| ROA | 21.2% | -32.0% | +53.2% |
| Current Ratio | 344.31 | 2.84 | +341.47 |
| Debt / Equity | — | 0.28 | — |